Michael J. Tokar

Array ( [id] => 10008067 [patent_doc_number] => 09051574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Non-hemolytic ClyA for excretion of proteins' [patent_app_type] => utility [patent_app_number] => 12/995644 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 22301 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151712 [patent_doc_number] => 08168195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Vaccines against Escherichia coli O157 infection' [patent_app_type] => utility [patent_app_number] => 12/471049 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10723 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168195.pdf [firstpage_image] =>[orig_patent_app_number] => 12471049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943904 [patent_doc_number] => 08497081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Botulinum toxin screening assays' [patent_app_type] => utility [patent_app_number] => 12/469569 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 47538 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12469569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315506 [patent_doc_number] => 20090280104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING SHIGA TOXIN AND SHIGA-LIKE TOXIN' [patent_app_type] => utility [patent_app_number] => 12/463943 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280104.pdf [firstpage_image] =>[orig_patent_app_number] => 12463943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371688 [patent_doc_number] => 20100075396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs' [patent_app_type] => utility [patent_app_number] => 12/434074 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 90821 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075396.pdf [firstpage_image] =>[orig_patent_app_number] => 12434074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943643 [patent_doc_number] => 20110104263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'CLAUDIN-4 BINDING PEPTIDES, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/989737 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16564 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104263.pdf [firstpage_image] =>[orig_patent_app_number] => 12989737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514844 [patent_doc_number] => 20090215151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Two-Step Immunization Procedure Against Chlamydia Infection' [patent_app_type] => utility [patent_app_number] => 12/402568 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5206 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215151.pdf [firstpage_image] =>[orig_patent_app_number] => 12402568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290078 [patent_doc_number] => 20100158950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'USE OF TETANUS TOXIN TO AMPLIFY INADEQUATE VOLUNTARY MUSCLE CONTRACTION OR TO IMPROVE MUSCLE TONE IN AN ANIMAL ACTIVELY VACCINATED AGAINST THE TOXIN AND A REGIMEN FOR TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/391662 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158950.pdf [firstpage_image] =>[orig_patent_app_number] => 12391662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142297 [patent_doc_number] => 20110129525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'MUCOSAL MEMBRANE RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/918400 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17625 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129525.pdf [firstpage_image] =>[orig_patent_app_number] => 12918400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367716 [patent_doc_number] => 20090305275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES' [patent_app_type] => utility [patent_app_number] => 12/389992 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11706 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305275.pdf [firstpage_image] =>[orig_patent_app_number] => 12389992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465059 [patent_doc_number] => 20090325259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'USE OF ADHESION MOLECULES AS BOND STRESS-ENHANCED NANOSCALE BINDING SWITCHES' [patent_app_type] => utility [patent_app_number] => 12/354693 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 34567 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12354693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5431614 [patent_doc_number] => 20090166200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'SERUM COMPONENTS THAT BIND TO THREAT AGENTS' [patent_app_type] => utility [patent_app_number] => 12/325020 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5685 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20090166200.pdf [firstpage_image] =>[orig_patent_app_number] => 12325020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232989 [patent_doc_number] => 08198430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Immunogenic sequences' [patent_app_type] => utility [patent_app_number] => 12/277077 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 6 [patent_no_of_words] => 6424 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198430.pdf [firstpage_image] =>[orig_patent_app_number] => 12277077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428149 [patent_doc_number] => 20090087459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'METHODS FOR TREATING EYE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/271573 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9072 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087459.pdf [firstpage_image] =>[orig_patent_app_number] => 12271573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13538 [patent_doc_number] => 07803623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate' [patent_app_type] => utility [patent_app_number] => 12/261166 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 17461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803623.pdf [firstpage_image] =>[orig_patent_app_number] => 12261166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101444 [patent_doc_number] => 07727531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases' [patent_app_type] => utility [patent_app_number] => 12/257420 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 9086 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727531.pdf [firstpage_image] =>[orig_patent_app_number] => 12257420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850522 [patent_doc_number] => 08877201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Bordetella outer-membrane protein antigens and methods of making and using the same' [patent_app_type] => utility [patent_app_number] => 12/680823 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 4434 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6263009 [patent_doc_number] => 20100297180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'BOTULINUM NEUROTOXIN VACCINE' [patent_app_type] => utility [patent_app_number] => 12/682544 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15292 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297180.pdf [firstpage_image] =>[orig_patent_app_number] => 12682544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9285720 [patent_doc_number] => 08642046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Cholera vaccines' [patent_app_type] => utility [patent_app_number] => 12/681951 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12267 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285408 [patent_doc_number] => 20090099083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 12/248764 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 10718 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099083.pdf [firstpage_image] =>[orig_patent_app_number] => 12248764 [rel_patent_id] =>[rel_patent_doc_number] =>)